Literature DB >> 15276876

Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose.

Sumiyo Umeda1, Gregory W Stagliano, Robert B Raffa.   

Abstract

Planarians (Dugesia dorotocephala) that were exposed for 1 h to cocaine (80 microM) or to the kappa-selective opioid receptor agonist U-50,488H (1 microM) displayed an abstinence-induced withdrawal syndrome, indicative of the development of physical dependence, when they were tested in cocaine- (or U-50,488H-) free water, but not when they were tested in cocaine- (or U-50,488H-) containing water. The withdrawal was manifested as a significant (P<0.05) decrease in the rate of planarian spontaneous locomotor activity over a 5-min observation period, using a recently designed metric. Co-exposure of the planarians to D-glucose (1 microM) or to 2-deoxy-D-glucose (2-DG, 1 microM), but not to L-glucose (1 microM), significantly attenuated (P<0.05) the development of physical dependence, shown by an attenuated withdrawal syndrome, from cocaine and U-50,488H. These results suggest that either D-glucose and 2-deoxy-D-glucose compete with a common cocaine and kappa-opioid transport mechanism or that the development of physical dependence (or the inhibition of abstinence-induced withdrawal) in planarians requires energy supplied from glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276876     DOI: 10.1016/j.brainres.2004.05.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'.

Authors:  Robert B Raffa; Gregory W Stagliano; Geoffrey Ross; Jenay A Powell; Austin G Phillips; Zhe Ding; Scott M Rawls
Journal:  Brain Res       Date:  2007-12-08       Impact factor: 3.252

2.  Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.

Authors:  Robert B Raffa; Federica Cavallo; Anna Capasso
Journal:  Eur J Pharmacol       Date:  2007-02-16       Impact factor: 4.432

3.  Guarana provides additional stimulation over caffeine alone in the planarian model.

Authors:  Dimitrios Moustakas; Michael Mezzio; Branden R Rodriguez; Mic Andre Constable; Margaret E Mulligan; Evelyn B Voura
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.